期刊文献+

多普勒超声、钼靶X线及磁共振成像在乳腺癌早期诊断和鉴别中的作用 被引量:17

The effect of Doppler ultrasound, X-ray mammography and MRI in early diagnosis and differential for breast cancer
原文传递
导出
摘要 目的探讨多普勒超声、钼靶X线以及磁共振(MRI)在乳腺癌早期诊断和鉴别中的应用价值。方法将因乳腺肿块入院检查的女性患者182例作为研究对象,均经多普勒超声、钼靶X线以及MRI三项检查,根据患者术后病理结果分析三种检测手段的价值。结果182例患者中患乳腺癌143例(78.7%),良性肿瘤39例(21.3%)。MRI的灵敏度明显高于其他两项,三项联用的准确度明显高于各单项(均P〈0.05)。结论多普勒超声、钼靶X线以及MRI在乳腺癌早期诊断和鉴别中各有优势,联合应用可在一定程度上提高准确率。 Objective To explore the applicated value of Doppler ultrasound,X-ray mammography and MRI in early diagnosis and differential for breast cancer. Methods 182 cases examine femaled patients,which were hospitalized to breast lumps as the object of study, they were confirmed by Doppler ultrasound, X-ray mammography and MRI three checks. Caccording to the patient after surgery, the pathology results were used to diagonosed the value of the three detection methods. Results 182 patients with breast cancer and 143 cases(78.7% ) ,benign tumors and 39 cases (21.3%), the sensitivity of MRI was significantly higher than the other two, three associated with the accuracy of the examination results was significantly higher than that of each individual (P 〈 0.05 ), the difference was statistically significant. Conclusion Doppler ultrasound, X-ray mammography and MRI are used in breast cancer in the early diagnosis, which have their own advantages, the combination can increase the accuracy to a certain extent.
作者 柯斌
出处 《中国基层医药》 CAS 2013年第8期1173-1175,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 乳腺肿瘤 超声检查 多普勒 乳房X线摄影术 磁共振成像 Breast neoplasms Ultrasoni ography, doppler Mammography Magnetic resonance imaging
  • 相关文献

参考文献16

二级参考文献104

共引文献703

同被引文献157

  • 1尹益民,任晓萍,潘文倩,艾红.高频超声及钼靶X线检查在乳腺癌诊断中的应用价值[J].西安交通大学学报(医学版),2012,33(5):572-575. 被引量:79
  • 2陈蓉,龚水根,张伟国,陈金华,何双梧,刘宝华,李增鹏.乳腺癌MRI形态学表现与病理、分子生物学相关性研究[J].中华放射学杂志,2004,38(6):620-625. 被引量:55
  • 3李洁冰,张艳华,张本平,盛成霞.联合应用超声与X线钼靶诊断乳腺小肿块的临床研究[J].实用肿瘤学杂志,2007,21(3):257-258. 被引量:10
  • 4郑绪才,彭德峰.钼靶X线导丝定位在乳腺微钙化病灶中的临床应用[J].中国美容医学,2011,20(z6) :119-120.
  • 5Staudacher L, Cottu PH, Diras V, et al. Platinum- based chemo- therapy in metastatic triple-negative breast cancer:the Institut Curie experience[J]. Ann Oncol, 2011,22 (4) : 848-856.
  • 6Pern F, Bogdanova N, SshRmann P, et al. Mutation analysis of BRCA 1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer[J]. PLoS One, 2012,7 (10) : e47993.
  • 7Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk [J]. J A MA ,2012,307(13) : 1394-1404.
  • 8Geyer FC, Rodrigues DN, Weigeh B, et al. Molecular classifica- tion of estrogen receptor-positive/luminal breast cancers[J]. Adv Anat Pathol, 2012,19 ( 1 ) : 39-53.
  • 9Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pa- thologists clinical practice guideline update [J]. J Clin Oncol, 2013,31 (31) :3997-4013.
  • 10Gonzalez-Angulo AM ,Timms KM ,Liu S,et al. Incidenceand outcome of BRCA mutations in un selected patients with triple receptor-negative breast cancer [J]. Clin Cancer Res,2011,17 (5) : 1082-1089.

引证文献17

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部